secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2026-07-15T00:39:46+00:00
Accession:  0001728117-26-000061
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio stockholders approve 4B authorized shares, new incentive plan, and note/warrant issuance
--------------------------------------------------------------------------------

- Stockholders approved charter amendment increasing authorized common shares from 700M to 4B.
- Stockholders approved restated 2019 Incentive Award Plan to increase shares available for issuance.
- Stockholders approved potential issuance of shares upon conversion of up to $72M in new 7.50% Convertible Senior Secured First Lien Notes due 2030 and exercise of 135.8M purchase warrants.
- Exchange offer for $200M 5.00% Convertible Senior Notes due 2027 closed on June 4, 2026, with new notes and warrants issued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811726000061/0001728117-26-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811726000061/goss-20260714.htm
  HTML page:      https://secwatch.observer/filing/0001728117-26-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer